FAKTOR OPTIONSSCHEIN - BIOGEN IDEC | Real-time Bid/Ask 10:25:45 2024-05-27 am EDT | ||
| 6.11 EUR / 6.52 EUR | +7.22% |
|
| Current month | -29.38% | ||
| 1 month | +39.90% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-05-27 | 5.91 | +0.34% |
| 24-05-24 | 5.89 | -34.41% |
| 24-05-23 | 8.98 | -8.18% |
| 24-05-22 | 9.78 | -9.11% |
| 24-05-21 | 10.76 | -19.94% |
Delayed Quote Börse Stuttgart
Last update May 27, 2024 at 09:12 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HD462W |
| ISIN | DE000HD462W5 |
| Date issued | 2024-03-27 |
| Strike | 198.2 $ |
| Maturity | Unlimited |
| Parity | 3.64 : 1 |
| Emission price | 10.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.02 € |
|---|---|
| Lowest since issue | 2.49 € |
| Spread | 0.41 € |
| Spread % | 6.30% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
217.8
USD
Average target price
286.1
USD
Spread / Average Target
+31.33%
- Stock Market
- Certificates
- Certificat
